Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Preferred Shares (2025)

Crescent Biopharma (CBIO) has disclosed Preferred Shares for 2 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • Quarterly Preferred Shares changed N/A to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $4.0 million for FY2025, N/A changed from the prior year.
  • Preferred Shares for Q4 2025 was $4.0 million at Crescent Biopharma, roughly flat from $4.0 million in the prior quarter.
  • The five-year high for Preferred Shares was $4.0 million in Q2 2025, with the low at $4.0 million in Q2 2025.